首页 > 最新文献

Annals of Cardiac Anaesthesia最新文献

英文 中文
Systemic mastocytosis successfully managed using CytoSorb® during cardiopulmonary bypass for aortic valve replacement. 在主动脉瓣置换术的心肺旁路过程中使用 CytoSorb® 成功控制了全身性肥大细胞增多症。
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-08-28 DOI: 10.4103/aca.aca_16_24
Adrien Gross, Sébastien Colombier, Lionel Arlettaz, Dominique Delay

Abstract: We describe the case of a 72-year-old male with a history of systemic mastocytosis scheduled for on-pump aortic valve replacement for severe aortic insufficiency. Anesthesia and peri-operative management included avoidance of histamine-releasing drugs, methylprednisolone and clemastin prophylaxis. Furthermore, a CytoSorb® cartridge has been added to the bypass circuit and hemoadsorption was performed throughout the entire cardiopulmonary bypass (CPB) duration. CytoSorb® is a hemoadsorption device designed to remove various cytokines and drugs from the blood. The use of CytoSorb® during CPB in our case was not associated with adverse events, and the patient did not present any allergic or anaphylactic reaction.

摘要:我们描述了一例 72 岁男性病例,他有系统性肥大细胞增多症病史,因严重主动脉瓣关闭不全而计划进行泵上主动脉瓣置换术。麻醉和围手术期管理包括避免使用组胺释放药物、甲基强的松龙和氯马斯汀预防。此外,还在旁路回路中加入了 CytoSorb® 血盒,并在整个心肺旁路(CPB)过程中进行血液吸附。CytoSorb® 是一种血液吸附装置,设计用于清除血液中的各种细胞因子和药物。在我们的病例中,CPB 期间使用 CytoSorb® 并未引起不良反应,患者也未出现任何过敏或过敏性反应。
{"title":"Systemic mastocytosis successfully managed using CytoSorb® during cardiopulmonary bypass for aortic valve replacement.","authors":"Adrien Gross, Sébastien Colombier, Lionel Arlettaz, Dominique Delay","doi":"10.4103/aca.aca_16_24","DOIUrl":"https://doi.org/10.4103/aca.aca_16_24","url":null,"abstract":"<p><strong>Abstract: </strong>We describe the case of a 72-year-old male with a history of systemic mastocytosis scheduled for on-pump aortic valve replacement for severe aortic insufficiency. Anesthesia and peri-operative management included avoidance of histamine-releasing drugs, methylprednisolone and clemastin prophylaxis. Furthermore, a CytoSorb® cartridge has been added to the bypass circuit and hemoadsorption was performed throughout the entire cardiopulmonary bypass (CPB) duration. CytoSorb® is a hemoadsorption device designed to remove various cytokines and drugs from the blood. The use of CytoSorb® during CPB in our case was not associated with adverse events, and the patient did not present any allergic or anaphylactic reaction.</p>","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Superior Vena Cava Syndrome after Epicardial Pacing Wires Removal. 心外膜起搏导线移除后的上腔静脉综合征
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-08-28 DOI: 10.4103/aca.aca_36_24
González-Suárez Susana, Carlos Sureda Barbosa, Teresa Jusset García-Navia

Abstract: Although most superior vena cava (SVC) syndromes are due to intrathoracic malignancies, some are iatrogenic, such as those following the intravenous implantation of pacemaker wires. To date, the occurrence of this syndrome after epicardial pacemaker removal has not been described. The initial auricular laceration after removal can be complicated by the administration of anticoagulant and antiplatelet drugs, forming a hematoma that compresses the SVC cranially. Therefore, standardized practice may be necessary in these patients to address anticoagulant and antiplatelet therapy, perform serial echocardiography, and pay attention to underlying symptoms, which may be insidious and delayed.

摘要:虽然大多数上腔静脉(SVC)综合征是由胸腔内恶性肿瘤引起的,但也有一些是先天性的,如静脉内植入起搏器导线后出现的上腔静脉综合征。迄今为止,心外膜起搏器移除后出现这种综合征的情况尚未见报道。摘除起搏器后最初的耳廓裂伤可能会因服用抗凝药物和抗血小板药物而复杂化,形成血肿,压迫颅内的 SVC。因此,可能有必要对这些患者进行标准化操作,以解决抗凝和抗血小板治疗问题,进行连续超声心动图检查,并关注可能隐匿和延迟出现的潜在症状。
{"title":"Superior Vena Cava Syndrome after Epicardial Pacing Wires Removal.","authors":"González-Suárez Susana, Carlos Sureda Barbosa, Teresa Jusset García-Navia","doi":"10.4103/aca.aca_36_24","DOIUrl":"https://doi.org/10.4103/aca.aca_36_24","url":null,"abstract":"<p><strong>Abstract: </strong>Although most superior vena cava (SVC) syndromes are due to intrathoracic malignancies, some are iatrogenic, such as those following the intravenous implantation of pacemaker wires. To date, the occurrence of this syndrome after epicardial pacemaker removal has not been described. The initial auricular laceration after removal can be complicated by the administration of anticoagulant and antiplatelet drugs, forming a hematoma that compresses the SVC cranially. Therefore, standardized practice may be necessary in these patients to address anticoagulant and antiplatelet therapy, perform serial echocardiography, and pay attention to underlying symptoms, which may be insidious and delayed.</p>","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Successful Awake Fiberoptic Bronchoscopy Intubation of a Cardiomorbid Patient: A Case Report. 成功为一名心脏病患者进行清醒纤维支气管镜插管:病例报告。
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-08-28 DOI: 10.4103/aca.aca_13_24
Qusai A Alsalah, Peter R Bael, Arein A M Abufara, Mohammad I Alsahouri, Yousef Abu Asbeh, Majde Hamamdh

Abstract: Bronchoscopy is a widely used technique for diagnostic and therapeutic purposes. Though it requires anesthesia, many options are available, depending on the patient's health status, the purpose of the procedure, and the type of bronchoscope used. One such health status is heart failure, a leading cause of death, and a common challenge of anesthesiology. We report a 60-year-old male patient who is a known case of heart failure with an ejection fraction of 15%, and an implanted cardioverter defibrillator, along with concurrent ischemic heart disease, diabetes mellitus, and hypertension, who presented complaining of dysphagia. This highly morbid patient was able to successfully undergo a bronchoscopic biopsy with nerve block anesthesia considering his inadequacy for conventional methods. This report aims to shed light on these challenging cases and alert anesthesiologists on how to manage such situations in patients with cardiac morbidities.

摘要:支气管镜检查是一种广泛用于诊断和治疗的技术。虽然它需要麻醉,但根据病人的健康状况、手术目的和所用支气管镜的类型,有许多选择。心力衰竭就是其中一种健康状况,它是导致死亡的主要原因,也是麻醉学的常见挑战。我们报告了一名 60 岁的男性患者,他已知患有射血分数为 15%的心力衰竭,植入了心脏除颤器,并同时患有缺血性心脏病、糖尿病和高血压,主诉吞咽困难。考虑到他无法使用传统方法,这名高度病态的患者在神经阻滞麻醉下成功接受了支气管镜活检。本报告旨在阐明这些具有挑战性的病例,并提醒麻醉医师如何处理心脏疾病患者的此类情况。
{"title":"A Successful Awake Fiberoptic Bronchoscopy Intubation of a Cardiomorbid Patient: A Case Report.","authors":"Qusai A Alsalah, Peter R Bael, Arein A M Abufara, Mohammad I Alsahouri, Yousef Abu Asbeh, Majde Hamamdh","doi":"10.4103/aca.aca_13_24","DOIUrl":"https://doi.org/10.4103/aca.aca_13_24","url":null,"abstract":"<p><strong>Abstract: </strong>Bronchoscopy is a widely used technique for diagnostic and therapeutic purposes. Though it requires anesthesia, many options are available, depending on the patient's health status, the purpose of the procedure, and the type of bronchoscope used. One such health status is heart failure, a leading cause of death, and a common challenge of anesthesiology. We report a 60-year-old male patient who is a known case of heart failure with an ejection fraction of 15%, and an implanted cardioverter defibrillator, along with concurrent ischemic heart disease, diabetes mellitus, and hypertension, who presented complaining of dysphagia. This highly morbid patient was able to successfully undergo a bronchoscopic biopsy with nerve block anesthesia considering his inadequacy for conventional methods. This report aims to shed light on these challenging cases and alert anesthesiologists on how to manage such situations in patients with cardiac morbidities.</p>","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maintaining a Bloodless Field for HeartMate 3 Placement: Splicing an RVAD Outflow Cannula into the CPB Venous Reservoir for Complete LV Emptying. 在放置 HeartMate 3 时保持无血视野:将 RVAD 流出管接头插入 CPB 静脉储液器以实现左心室完全排空。
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-08-28 DOI: 10.4103/aca.aca_18_24
Justin W Walker, S Michael Roberts

Abstract: Over the previous 20 years, the use of extracorporeal membranous oxygenation (ECMO) as a bridge to durable left ventricular assist device (dLVAD) increased significantly. Additionally, emerging literature has demonstrated a protective effect of biventricular decompression while on ECMO, with one such strategy including a temporary LVAD and right ventricular assist device (RVAD). The complexity of these operations is increased by the frequency of re-sternotomies, which result in adhesions and difficult access to traditional cannulation sites. In this case report, we present a patient presenting for a re-sternotomy for dLVAD on biventricular support in whom the RVAD outflow cannula was spliced into the cardiopulmonary bypass venous reservoir by the cardiac anesthesiologist. This innovative cannulation strategy allowed for continuation of RVAD flows to prevent thrombosis and active venting of the pulmonary artery to facilitate a bloodless surgical field.

摘要:在过去的 20 年中,使用体外膜肺氧合(ECMO)作为连接耐用左心室辅助装置(dLVAD)的桥梁的情况显著增加。此外,新出现的文献表明,在使用 ECMO 时进行双心室减压具有保护作用,其中一种策略包括临时性 LVAD 和右心室辅助装置 (RVAD)。这些手术的复杂性因频繁进行再次脑室切开术而增加,再次脑室切开术会导致粘连和难以进入传统插管部位。在本病例报告中,我们介绍了一名在双心室支持下为 dLVAD 进行再司空切术的患者,心脏麻醉师将其 RVAD 流出道插管连接到了心肺旁路静脉储库中。这种创新的插管策略使 RVAD 的血流得以持续以防止血栓形成,并使肺动脉主动通气,从而实现无血手术野。
{"title":"Maintaining a Bloodless Field for HeartMate 3 Placement: Splicing an RVAD Outflow Cannula into the CPB Venous Reservoir for Complete LV Emptying.","authors":"Justin W Walker, S Michael Roberts","doi":"10.4103/aca.aca_18_24","DOIUrl":"https://doi.org/10.4103/aca.aca_18_24","url":null,"abstract":"<p><strong>Abstract: </strong>Over the previous 20 years, the use of extracorporeal membranous oxygenation (ECMO) as a bridge to durable left ventricular assist device (dLVAD) increased significantly. Additionally, emerging literature has demonstrated a protective effect of biventricular decompression while on ECMO, with one such strategy including a temporary LVAD and right ventricular assist device (RVAD). The complexity of these operations is increased by the frequency of re-sternotomies, which result in adhesions and difficult access to traditional cannulation sites. In this case report, we present a patient presenting for a re-sternotomy for dLVAD on biventricular support in whom the RVAD outflow cannula was spliced into the cardiopulmonary bypass venous reservoir by the cardiac anesthesiologist. This innovative cannulation strategy allowed for continuation of RVAD flows to prevent thrombosis and active venting of the pulmonary artery to facilitate a bloodless surgical field.</p>","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ibrutinib-Induced Ventricular Electrical Storm Successfully Managed with Veno-Arterial ECMO and Intralipid Administration: A Rare Case Report. 伊布替尼诱发的心室电风暴通过静脉-动脉 ECMO 和血脂内注射成功控制:罕见病例报告。
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-08-28 DOI: 10.4103/aca.aca_4_24
Debora E Torre, Carla Stecco, Andrea Porzionato, Domenico Mangino, Veronica Macchi, Raffaele De Caro, Carmelo Pirri

Abstract: We report a 55-year-old men patient with a primitive central nervous system non-Hodgkin lymphoma B cell (LNH PNSLC), treated with chemotherapy rituximab, methotrexate, and ibrutinib (first treatment) who developed a refractory ventricular arrhythmic storm two hours after the ibrutinib intake. Indeed, ibrutinib could be associated with severe and occasionally fatal cardiac events. The swift emergence of a ventricular electrical storm with cardiac arrest demanded the prompt initiation of veno-arterial extracorporeal membrane oxygenation to effectively navigate this critically ill patient toward recovery. This intervention was deemed imperative, given the absence of any available antidote for the effects of ibrutinib. Veno-arterial extracorporeal membrane oxygenation proved successful in rescuing this patient, resulting in a complete neurological recovery. Consequently, he was able to resume his chemotherapy treatment.

摘要:我们报告了一名55岁的男性原始中枢神经系统非霍奇金淋巴瘤B细胞(LNH PNSLC)患者,该患者接受过利妥昔单抗、甲氨蝶呤和伊布替尼(首次治疗)化疗,在服用伊布替尼两小时后出现难治性室性心律失常风暴。事实上,伊布替尼可能与严重的、偶尔致命的心脏事件有关。心室电风暴的迅速出现和心脏骤停要求及时启动静脉-动脉体外膜肺氧合,以有效地引导这名重症患者走向康复。考虑到目前还没有针对伊布替尼作用的解毒剂,这一干预措施势在必行。事实证明,静脉-动脉体外膜氧合成功地挽救了这名患者,使其神经系统完全康复。因此,他得以继续接受化疗。
{"title":"Ibrutinib-Induced Ventricular Electrical Storm Successfully Managed with Veno-Arterial ECMO and Intralipid Administration: A Rare Case Report.","authors":"Debora E Torre, Carla Stecco, Andrea Porzionato, Domenico Mangino, Veronica Macchi, Raffaele De Caro, Carmelo Pirri","doi":"10.4103/aca.aca_4_24","DOIUrl":"https://doi.org/10.4103/aca.aca_4_24","url":null,"abstract":"<p><strong>Abstract: </strong>We report a 55-year-old men patient with a primitive central nervous system non-Hodgkin lymphoma B cell (LNH PNSLC), treated with chemotherapy rituximab, methotrexate, and ibrutinib (first treatment) who developed a refractory ventricular arrhythmic storm two hours after the ibrutinib intake. Indeed, ibrutinib could be associated with severe and occasionally fatal cardiac events. The swift emergence of a ventricular electrical storm with cardiac arrest demanded the prompt initiation of veno-arterial extracorporeal membrane oxygenation to effectively navigate this critically ill patient toward recovery. This intervention was deemed imperative, given the absence of any available antidote for the effects of ibrutinib. Veno-arterial extracorporeal membrane oxygenation proved successful in rescuing this patient, resulting in a complete neurological recovery. Consequently, he was able to resume his chemotherapy treatment.</p>","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Internal Jugular Vein Valve Dysfunction and Venous Dissection-Complications of Central Venous Catheterization. 颈内静脉瓣膜功能障碍和静脉解剖--中心静脉导管插入术的并发症。
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-08-28 DOI: 10.4103/aca.aca_65_24
Miho Ogawa, Jun Honda, Keisuke Yoshida, Tatsumi Yakushiji, Satoki Inoue
{"title":"Internal Jugular Vein Valve Dysfunction and Venous Dissection-Complications of Central Venous Catheterization.","authors":"Miho Ogawa, Jun Honda, Keisuke Yoshida, Tatsumi Yakushiji, Satoki Inoue","doi":"10.4103/aca.aca_65_24","DOIUrl":"https://doi.org/10.4103/aca.aca_65_24","url":null,"abstract":"","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Shared Airway: Tracheal Mass Excision. 共享气道气管肿块切除术
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-08-28 DOI: 10.4103/aca.aca_47_24
Amruta Shringarpure, Surendhar Saba, Sanjeeta Umbarkar, Manjula Sarkar

Abstract: We report a case of successful airway management of a 26-year-old male patient who was posted for tracheal mass excision. The main challenge in such a case is to formulate a plan to provide maximum surgical access to the trachea for mass excision through an intraoral approach while ensuring adequate oxygenation and airway management. The patient presented with acute respiratory distress in the emergency ward. On computed tomography (CT), the patient was diagnosed with a polypoidal tracheal tumor occluding more than 90% of the tracheal lumen and 5.8 cm away from the carina. The case was successfully managed using a peripheral bypass for airway management. After the removal of the tumor, a tracheostomy tube was placed through the tracheotomy hole used for tumor excision. The whole process was uneventful.

摘要:我们报告了一例成功处理气道的病例,患者是一名 26 岁的男性,因气管肿块切除术而被派往手术室。此类病例的主要挑战在于如何制定计划,通过口腔内入路最大限度地进入气管进行肿块切除手术,同时确保充足的氧合和气道管理。患者在急诊室出现急性呼吸窘迫。经计算机断层扫描(CT),患者被诊断为多发性气管肿瘤,堵塞了90%以上的气管腔,距离心尖5.8厘米。该病例采用外周分流术成功地进行了气道管理。切除肿瘤后,通过用于切除肿瘤的气管切开孔置入气管造口管。整个过程非常顺利。
{"title":"The Shared Airway: Tracheal Mass Excision.","authors":"Amruta Shringarpure, Surendhar Saba, Sanjeeta Umbarkar, Manjula Sarkar","doi":"10.4103/aca.aca_47_24","DOIUrl":"https://doi.org/10.4103/aca.aca_47_24","url":null,"abstract":"<p><strong>Abstract: </strong>We report a case of successful airway management of a 26-year-old male patient who was posted for tracheal mass excision. The main challenge in such a case is to formulate a plan to provide maximum surgical access to the trachea for mass excision through an intraoral approach while ensuring adequate oxygenation and airway management. The patient presented with acute respiratory distress in the emergency ward. On computed tomography (CT), the patient was diagnosed with a polypoidal tracheal tumor occluding more than 90% of the tracheal lumen and 5.8 cm away from the carina. The case was successfully managed using a peripheral bypass for airway management. After the removal of the tumor, a tracheostomy tube was placed through the tracheotomy hole used for tumor excision. The whole process was uneventful.</p>","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Neutrophil-Lymphocyte Ratio and Red Blood Cell Distribution Width with Poor Outcome in Pediatric Cardiac Surgery - A Retrospective Observational Study. 中性粒细胞-淋巴细胞比率和红细胞分布宽度与小儿心脏手术不良预后的关系--一项回顾性观察研究。
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-04 DOI: 10.4103/aca.aca_9_24
Alok Kumar, Monika Aggarwal, Akash Mohapatra, Nihar Ameta

Background: Neutrophil-lymphocyte ratio (NLR) is a valuable indicator for evaluating inflammatory response and red blood cell distribution width (RBDW), a routinely available biomarker of likely erythropoietic dysfunction, which may be associated with adverse outcomes after cardiac surgery. This study aimed to investigate the association between these two readily available haematological parameters, with the poor outcomes in paediatric patients undergoing cardiac surgery.

Methods: A comprehensive review of medical records for paediatric patients who underwent cardiac surgery at our tertiary care centre between April 2022 and June 2023 was carried out. RBDW and NLR values were collected from complete blood count reports obtained on admission to the ICU. Demographic data, surgical details, and postoperative complications were also recorded. A receiver operating characteristic (ROC) curve and multivariable logistic regression were applied to identify the prognosis performance of preoperative NLR and RBDW for poor outcomes.

Results: The study included 219 patients meeting the inclusion criteria of which a total of 90 (41%) children experienced at least one of the poor outcomes. Preoperative NLR (AUC=0.88, 95%CI 0.36-0.70, cut off- 4.2) and RBDW (AUC=0.88, 95%CI 0.39-0.73, cut off- 18.5%) showed prognostic significance in the perioperative period.

Conclusion: This retrospective observational study highlights a significant association between elevated Red Blood Cell Distribution Width (RBDW) and Neutrophil Lymphocyte Ratio (NLR) values and poor outcomes in paediatric patients undergoing cardiac surgery. These readily available haematological parameters could serve as potential prognostic indicators for identifying patients at risk of poor outcomes.

背景:中性粒细胞-淋巴细胞比值(NLR)是评估炎症反应的重要指标,而红细胞分布宽度(RBDW)是红细胞生成功能障碍的常规生物标志物,可能与心脏手术后的不良预后有关。本研究旨在调查这两个现成的血液学参数与接受心脏手术的儿科患者不良预后之间的关系:方法:对 2022 年 4 月至 2023 年 6 月期间在我们的三级医疗中心接受心脏手术的儿科患者的病历进行了全面审查。RBDW和NLR值是从重症监护室入院时获得的全血细胞计数报告中收集的。此外,还记录了人口统计学数据、手术细节和术后并发症。应用接收器操作特征曲线(ROC)和多变量逻辑回归确定术前 NLR 和 RBDW 对不良预后的影响:研究共纳入219名符合纳入标准的患者,其中90名(41%)患儿至少出现一种不良预后。术前NLR(AUC=0.88,95%CI 0.36-0.70,切点4.2)和RBDW(AUC=0.88,95%CI 0.39-0.73,切点18.5%)在围手术期显示出预后意义:这项回顾性观察研究强调了红细胞分布宽度(RBDW)和中性粒细胞淋巴细胞比值(NLR)升高与接受心脏手术的儿科患者不良预后之间的显著关联。这些现成的血液学参数可作为潜在的预后指标,用于识别有不良预后风险的患者。
{"title":"Association of Neutrophil-Lymphocyte Ratio and Red Blood Cell Distribution Width with Poor Outcome in Pediatric Cardiac Surgery - A Retrospective Observational Study.","authors":"Alok Kumar, Monika Aggarwal, Akash Mohapatra, Nihar Ameta","doi":"10.4103/aca.aca_9_24","DOIUrl":"10.4103/aca.aca_9_24","url":null,"abstract":"<p><strong>Background: </strong>Neutrophil-lymphocyte ratio (NLR) is a valuable indicator for evaluating inflammatory response and red blood cell distribution width (RBDW), a routinely available biomarker of likely erythropoietic dysfunction, which may be associated with adverse outcomes after cardiac surgery. This study aimed to investigate the association between these two readily available haematological parameters, with the poor outcomes in paediatric patients undergoing cardiac surgery.</p><p><strong>Methods: </strong>A comprehensive review of medical records for paediatric patients who underwent cardiac surgery at our tertiary care centre between April 2022 and June 2023 was carried out. RBDW and NLR values were collected from complete blood count reports obtained on admission to the ICU. Demographic data, surgical details, and postoperative complications were also recorded. A receiver operating characteristic (ROC) curve and multivariable logistic regression were applied to identify the prognosis performance of preoperative NLR and RBDW for poor outcomes.</p><p><strong>Results: </strong>The study included 219 patients meeting the inclusion criteria of which a total of 90 (41%) children experienced at least one of the poor outcomes. Preoperative NLR (AUC=0.88, 95%CI 0.36-0.70, cut off- 4.2) and RBDW (AUC=0.88, 95%CI 0.39-0.73, cut off- 18.5%) showed prognostic significance in the perioperative period.</p><p><strong>Conclusion: </strong>This retrospective observational study highlights a significant association between elevated Red Blood Cell Distribution Width (RBDW) and Neutrophil Lymphocyte Ratio (NLR) values and poor outcomes in paediatric patients undergoing cardiac surgery. These readily available haematological parameters could serve as potential prognostic indicators for identifying patients at risk of poor outcomes.</p>","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141496914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Dexmedetomidine on Perioperative Glycemic Control in Adult Diabetic Patients Undergoing Cardiac Surgery. 右美托咪定对接受心脏手术的成年糖尿病患者围术期血糖控制的影响
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-04 DOI: 10.4103/aca.aca_209_23
Nagarjuna Panidapu, Saravana Babu, Shrinivas V Gadhinglajkar, Diana Thomas, Azeez Mahammad Aspari, Barsha Sen

Background and objective: To study the effects of dexmedetomidine (DEX) on perioperative blood glucose levels in adult diabetes mellitus (DM) patients undergoing cardiac surgery.

Methods and material: A prospective, observational study was conducted on 100 adult diabetic patients aged between 18 and 75 years undergoing cardiac surgery with cardiopulmonary bypass (CPB). The patients were divided into two groups (group D and group C) of 50 each. Group D patients received DEX infusion, whereas the group C patients received 0.9% normal saline infusion.

Results: The blood glucose levels, heart rate, mean arterial pressure, and serum potassium levels at different time points were comparable between the two groups (P > 0.05). The mean dose of insulin required in the combined population as well as in both controlled and uncontrolled DM patients was significantly less in group D than in group C (combined population - 36.03 ± 22.71 vs 47.82 ± 30.19 IU, P = 0.0297; uncontrolled DM - 37.36 ± 23.9 IU vs 48.16 ± 25.15 IU, P = 0.0301; controlled DM - 34.7 ± 21.5 IU vs 47.63 ± 35.25 IU, P = 0.0291). Duration of mechanical ventilation and VIS were comparable between the two groups. The incidence of arrhythmias (20% vs 46%, P = 0.0059) and delirium (6% vs 20%, P = 0.0384) was significantly less in group D than in group C. None of the patients in either group had stroke, myocardial ischemia, and mortality.

Conclusion: The results suggested that DEX infusion during the intraoperative period was very effective for perioperative glycemic control and reduction of insulin requirement in DM patients undergoing cardiac surgery.

背景和目的研究右美托咪定(DEX)对接受心脏手术的成年糖尿病(DM)患者围手术期血糖水平的影响:对 100 名接受心肺旁路(CPB)心脏手术的 18 至 75 岁成年糖尿病患者进行了前瞻性观察研究。患者被分为两组(D 组和 C 组),每组 50 人。D 组患者输注 DEX,C 组患者输注 0.9% 生理盐水:结果:两组患者在不同时间点的血糖水平、心率、平均动脉压和血清钾水平相当(P > 0.05)。D组患者所需的胰岛素平均剂量明显少于C组(两组患者:36.03 ± 22.71 IU vs 47.82 ± 30.19 IU,P = 0.0297;未受控DM患者:37.36 ± 23.9 IU vs 48.16 ± 25.15 IU,P = 0.0301;受控DM患者:34.7 ± 21.5 IU vs 47.63 ± 35.25 IU,P = 0.0291)。两组患者的机械通气和 VIS 持续时间相当。D组心律失常(20% vs 46%,P = 0.0059)和谵妄(6% vs 20%,P = 0.0384)的发生率明显低于C组:结果表明,在术中输注 DEX 对心脏手术 DM 患者围术期血糖控制和减少胰岛素需求非常有效。
{"title":"Effects of Dexmedetomidine on Perioperative Glycemic Control in Adult Diabetic Patients Undergoing Cardiac Surgery.","authors":"Nagarjuna Panidapu, Saravana Babu, Shrinivas V Gadhinglajkar, Diana Thomas, Azeez Mahammad Aspari, Barsha Sen","doi":"10.4103/aca.aca_209_23","DOIUrl":"10.4103/aca.aca_209_23","url":null,"abstract":"<p><strong>Background and objective: </strong>To study the effects of dexmedetomidine (DEX) on perioperative blood glucose levels in adult diabetes mellitus (DM) patients undergoing cardiac surgery.</p><p><strong>Methods and material: </strong>A prospective, observational study was conducted on 100 adult diabetic patients aged between 18 and 75 years undergoing cardiac surgery with cardiopulmonary bypass (CPB). The patients were divided into two groups (group D and group C) of 50 each. Group D patients received DEX infusion, whereas the group C patients received 0.9% normal saline infusion.</p><p><strong>Results: </strong>The blood glucose levels, heart rate, mean arterial pressure, and serum potassium levels at different time points were comparable between the two groups (P > 0.05). The mean dose of insulin required in the combined population as well as in both controlled and uncontrolled DM patients was significantly less in group D than in group C (combined population - 36.03 ± 22.71 vs 47.82 ± 30.19 IU, P = 0.0297; uncontrolled DM - 37.36 ± 23.9 IU vs 48.16 ± 25.15 IU, P = 0.0301; controlled DM - 34.7 ± 21.5 IU vs 47.63 ± 35.25 IU, P = 0.0291). Duration of mechanical ventilation and VIS were comparable between the two groups. The incidence of arrhythmias (20% vs 46%, P = 0.0059) and delirium (6% vs 20%, P = 0.0384) was significantly less in group D than in group C. None of the patients in either group had stroke, myocardial ischemia, and mortality.</p><p><strong>Conclusion: </strong>The results suggested that DEX infusion during the intraoperative period was very effective for perioperative glycemic control and reduction of insulin requirement in DM patients undergoing cardiac surgery.</p>","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141496920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vasoactive-Inotropic Scoring in Cardiac Surgery: Both Concept and Context Matter! 心脏手术中的血管活性-肌张力评分:概念和背景都很重要
IF 1.1 Q3 ANESTHESIOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-04 DOI: 10.4103/aca.aca_23_24
Jaffrey Kalaiselvan, Rohan Magoon, Ramesh C Kashav, Jes Jose
{"title":"Vasoactive-Inotropic Scoring in Cardiac Surgery: Both Concept and Context Matter!","authors":"Jaffrey Kalaiselvan, Rohan Magoon, Ramesh C Kashav, Jes Jose","doi":"10.4103/aca.aca_23_24","DOIUrl":"10.4103/aca.aca_23_24","url":null,"abstract":"","PeriodicalId":7997,"journal":{"name":"Annals of Cardiac Anaesthesia","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141496935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Cardiac Anaesthesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1